Stock BOLT BIOLIGHT LIFE SCIENCES LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News BioLight Life Sciences Ltd.

Equities

BOLT

IL0010952237

Market Closed - TEL AVIV STOCK EXCHANGE
Other stock markets
 10:24:12 2024-05-16 am EDT 		5-day change 1st Jan Change
427.1 ILa -0.84% Intraday chart for BioLight Life Sciences Ltd. -4.81% -17.82%
May. 05 Alcon Management S.A. entered into an agreement to acquire BELKIN Vision Ltd. form BioLight Life Sciences Ltd. and others for ILS 49.1 million. CI
Mar. 21 BioLight Life Sciences Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Alcon Management S.A. entered into an agreement to acquire BELKIN Vision Ltd. form BioLight Life Sciences Ltd. and others for ILS 49.1 million.
CI
BioLight Life Sciences : Calling of Special Meeting for May 9, 2024 - Company announcement
PU
BioLight Life Sciences Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
BioLight Life Sciences : Calling of Annual Meeting for April 8, 2024 - Company announcment
PU
BioLight Life Sciences Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Diagnostear, a subsidiary of BioLight Life Sciences Ltd, signed a binding Letter of Intent for merger, capital raise and listing on the Canadian Securities Exchange
PR
BioLight Life Sciences Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
BioLight Life Sciences Announces Results from its Glaucoma Insert VS101 Phase 1/2A Clinical Trial
CI
DiagnosTear Ltd. to Provide Analysis Services Through its TeaRx Multi-Parameter Diagnostic Assays for Use in an Clinical Trial for Dry Eye Syndrome
CI
A Chinese investor signed Memorandum of Understanding to acquire 45% stake in BioLight Life Sciences Ltd. from public for ILS 19.4 million.
CI
BioLight Reports Feasibility Clinical Study Results for the Detection of Prostate Cancer with CellDetect® Non-Invasive Test
CI
BioLight Life Sciences Ltd. Receives worldwide rights for Eye Drops for Dry Eye Syndrome
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BOLT Stock
  4. News BioLight Life Sciences Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW